Press Release Details
For More Information, Contact:
Brian P. Callahan, Chief Financial Officer
(615) 261-1500
bcallahan@spheris.com
Lisa DeMoss
Director, Marketing and Communications
(615) 261-1716
ldemoss@spheris.com
For Immediate Release
Spheris Sets Third Quarter 2007 Earnings Release and Conference Call Dates
Franklin, TN — October 22, 2007 — Spheris, a leading global outsource provider of clinical documentation technology and services, today announced results for the three and six months ended June 30, 2007.Financial Highlights—Second Quarter of 2007
Net revenues for the second quarter of 2007 were $50.5 million compared with $52.3 million in the second quarter of 2006. The decrease in net revenues during the second quarter of 2007 from the prior-year period was primarily due to delayed implementations of signed new business. Operating income was $2.5 million during the second quarter of 2007 compared with $1.1 million during the prior-year period. Operating income increased $1.4 million period over period primarily as a result of increased utilization of the Company's global production capabilities, lower medical language specialist (MLS) direct costs and decreased depreciation expense.
Earnings before interest, taxes, depreciation and amortization (EBITDA) were $8.0 million in the second quarter of 2007 compared with $7.6 million in the prior-year period. The increase in EBITDA was primarily due to increased utilization of the Company's global production capabilities and lower MLS direct costs. The Company's net loss was $1.8 million during the second quarter of 2007 compared with a net loss of $2.8 million during the same period in 2006. The decrease in net loss during the current year period was primarily due to improvements in operating income, off-set by higher interest expense associated with variable interest rates on the Company's senior credit facilities.
EBITDA is a non-GAAP financial measure. Please refer to the "Supplemental Financial Information" and related note contained in this press release for further discussion and reconciliation of GAAP financial measures to EBITDA.
Financial Highlights—First Six Months of 2007
Net revenues for the first six months of 2007 were $102.9 million compared with $104.3 million in the first six months of 2006. The decrease in net revenues during the first half of 2007 as compared to the prior-year period was primarily due to delayed implementations of signed new business. Operating income was $4.6 million during the first six months of 2007 compared with $2.2 million during the prior-year period. The $2.4 million increase in operating income resulted primarily from increased utilization of the Company's global production capabilities, lower MLS direct costs and decreased depreciation expense.
EBITDA was $16.2 million in the first six months of 2007 compared with $15.3 million in the prior-year period. The increase in EBITDA was primarily due to increased utilization of the Company's global production capabilities and lower MLS direct costs. The Company's net loss during the first six months of 2007 was $4.0 million compared with $5.7 million in the prior-year period. The decrease in net loss during the current period was primarily due to improvements in operating income, off-set by higher interest expense associated with variable interest rates on the Company's senior credit facilities.
Commenting on the results, Steven E. Simpson, president and chief executive officer of Spheris, stated, "The year over year EBITDA growth we achieved during the second quarter is clear evidence of the progress being made on our major strategic initiatives. Operational efficiencies resulting from increased utilization of our global resources, achievement of key technology milestones related to our Spheris Clarity™ platform, and further deployment of speech recognition to our customers continue to drive momentum in our business and position Spheris for long-term success."
Simpson added, "As we have stated previously, although the main planks of our strategy are working well, we consider 2007 to be a building year and expect new revenue growth to accelerate in 2008 and beyond as customers in the clinical documentation industry begin to embrace our best-in-class blended offering of technology and services."
Balance Sheet Highlights
As of June 30, 2007, the outstanding indebtedness under the Company's senior secured credit facilities was $73.3 million and the outstanding indebtedness under the Company's senior subordinated notes was $125.0 million. On July 17, 2007, the Company entered into a new financing agreement to replace the Company's existing senior credit facility. In addition to providing additional financing flexibility, the refinancing was driven by more favorable margin rates on the interest elections available under the new facility and additional capacity for borrowings under the revolving loan portion of the new facility.
Liquidity Highlights
As of June 30, 2007, Spheris held $13.2 million in unrestricted cash and cash equivalents. During the first half of 2007, the Company generated cash from operating activities of $9.4 million compared with $3.2 million of cash generated from operating activities during the first half of 2006. The $6.2 million increase over the prior-year period primarily reflects operating income improvements, improved collections on accounts receivable and the timing of interest payments on the Company's senior secured credit facilities.
Investor Conference Call and Webcast
Spheris will host a conference call on August 10, 2007, at 8:00 a.m. CDT. The number to call for this interactive teleconference is (913) 981-5581. Following the conference call, the audio replay will be available for one week by dialing (719) 457-0820 and entering the confirmation number, 8599324. The live broadcast of Spheris' quarterly conference call also will be available online at www.spheris.com and http://www.videonewswire.com/event.asp?id=41188on August 10, 2007, at 8:00 a.m. CT. The online replay will be available on Spheris' website shortly after the call and will continue for 30 days.
Forward-Looking Statements
This press release contains statements as to the Company's beliefs and expectations of the outcome of future events that are forward-looking statements as defined within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties as described in the filings made from time to time by the Company with the Securities and Exchange Commission, including, without limitation, the following: (i) the effect our substantial indebtedness has on our ability to raise additional capital to fund our business, to react to changes in the economy or our business and to fulfill our obligations under our indebtedness, including our senior secured credit facilities and indenture relating to our senior subordinated notes; (ii) our history of losses and accumulated deficit; (iii) our ability to effectively manage our global production capacity, including our ability to recruit, train and retain qualified medical language specialists and other technical and managerial personnel and to maintain high standards of quality service in our operations; (iv) our ability to adapt and integrate new technology into our clinical documentation platforms to improve our production capabilities and expand the breadth of our service offerings; (v) our ability to maintain our competitive position against current and future competitors, including our ability to gain new business with acceptable operating margins and ongoing price pressures related to our services and the healthcare market in general; (vi) the reluctance of potential customers to outsource or change providers of their clinical documentation services and its impact on our ability to attract new customers and increase revenues; (vii) the effect on our business if we incur additional debt, contingent liabilities and expenses in connection with future acquisitions or if we cannot effectively integrate newly acquired operations; (viii) our ability to adequately protect our intellectual property rights, including our proprietary technology and the intellectual property we license from third parties; and (ix) financial and operational risks inherent in our global operations, including foreign currency rate fluctuations and transfer pricing laws between the United States and India.
The Company takes no responsibility for updating the information contained in this press release following the date hereof to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events or for any changes or modifications made to this press release.
Note to Supplemental Financial Information
Earnings before interest expense, income taxes, depreciation and amortization, or EBITDA, is a financial measure not computed in accordance with United States generally accepted accounting principles, or GAAP. The Company believes that this non-GAAP measure, when presented in conjunction with the comparable GAAP measure, is useful to both management and investors in analyzing the Company's ongoing business and operating performance. The Company believes that providing the non-GAAP information to investors, in addition to the GAAP presentation, allows investors to view the Company's financial results in the way management and the Company's senior lenders view the Company's operating results. Management believes EBITDA is useful as a supplemental measure of the performance of the Company's operations because it isolates the Company's operating performance from the accounting impact of the Company's financing strategies, tax provisions and depreciation and amortization. Additionally, since EBITDA is a significant component of certain financial covenants under the Company's senior secured credit facilities agreement, management believes EBITDA is useful for investors to better assess the Company's compliance with these financial covenants. Management believes EBITDA should be considered in addition to, but not as a substitute for, items prepared in accordance with GAAP that are presented in this release, as the items excluded in the presentation of EBITDA are significant components in understanding and assessing financial performance. A reconciliation of EBITDA to the nearest comparable GAAP financial measure is provided above. EBITDA, as presented, may not be comparable to similarly titled measures of other companies.
About Spheris Spheris is a leading provider of clinical documentation services and technology to health systems, hospitals and group practices throughout the U.S. Founded by physicians in 1993, Spheris employs a global network of medical language specialists for true 24-hour service, seven days a week, 365 days a year. The proprietary Spheris Clarity™ technology platform integrates the full range of clinical documentation software and hardware into one seamless, customizable system, including embedded speech recognition technologies. The Spheris solution is flexible and scalable to balance the needs of HIM directors, CFOs, IT directors and physicians with an emphasis on verifiable quality, turnaround time, security and pricing. Spheris' worldwide corporate headquarters is located in Franklin, Tenn. For more information, please visit www.spheris.com.